ALMUDENA CASCAJERO DIAZ at Instituto de Salud Carlos III - Research Interests, Publications & Academic Profile

ALMUDENA CASCAJERO DIAZ

Técnico Superior de Actividades Técnicas y Profesionales

Instituto de Salud Carlos III

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

40%

Immunology

40%

Sars-cov-2

30%

Vaccine Development

30%

Covid-19

20%

Influenza Research

20%

Immunotherapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles8

Characterisation of <i>Legionella</i> Clinical Isolates in Spain from 2012 to 2022.

Article Link

Year:

2024

Fulminant septic shock due to community-acquired pneumonia caused by Legionella pneumophila SG1 Olda OLDA ST1. Case report

Article Link

Year:

2024

Longer intervals between SARS‐CoV‐2 infection and mRNA‐1273 doses improve the neutralization of different variants of concern

Article Link

Year:

2023

Treatment with integrase inhibitors alters SARS‐CoV‐2 neutralization levels measured with HIV‐based pseudotypes in people living with HIV

Article Link

Year:

2023

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

Article Link

Year:

2022

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

Article Link

Year:

2022

Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19

Article Link

Year:

2022

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Article Link

Year:

2021

Collaborators6

Fernando González-Camacho

Instituto de Salud Carlos III

SPAIN

Antonio Portolés-Pérez

Profesor Titular Vinculado

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

Alberto M. Borobia

SPAIN

Miguel Ángel García Garrido

Profesor. Coordinador de Prácticas Clínicas

Universidad Alfonso X el Sabio

SPAIN

Oleguer Parés-Badell

Assistant professor

University of Barcelona

SPAIN

Francisco Díez-Fuertes

Instituto de Salud Carlos III

SPAIN

How do I reach out?

Meet Kite AI